{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Song S"],"pubmed_abstract":["<h4>Background</h4>Atrial fibrillation (AF) is treated by heart rate (HR) control. However, the optimal HR target in AF patients with heart failure (HF) remains unclear. To evaluate the clinical implication of the resting HR in AF patients with HF accompanied by preserved, mid-range, or reduced ejection fraction (HFpEF, HFmrEF, or HFrEF, respectively).<h4>Methods</h4>Echocardiographic data from June 2016 to April 2020 in a prospective, multicenter, observational registry from 11,104 patients were analyzed. The follow-up duration was 2.2 years. The main outcome was composite of death and hospitalization. We categorized patients according to the HF type and resting HR: ≤ 60 bpm, 61-80 bpm, 81-110 bpm, and >110 bpm.<h4>Results</h4>A total of 1,421 patients were enrolled in the study: 582 in t"],"journal":["Frontiers in cardiovascular medicine"],"pagination":["787869"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8980522"],"repository":["biostudies-literature"],"pubmed_title":["Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry)."],"pmcid":["PMC8980522"],"pubmed_authors":["Lee HA","Kim C","Choi EK","Park J","Park JK","Kang KW","Kim J","Shim J","Kim TH","Joung B","Park HW","Ko JS","Uhm JS","Song S","Lee JM","Cha MJ","Kim JB"],"additional_accession":[]},"is_claimable":false,"name":"Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry).","description":"<h4>Background</h4>Atrial fibrillation (AF) is treated by heart rate (HR) control. However, the optimal HR target in AF patients with heart failure (HF) remains unclear. To evaluate the clinical implication of the resting HR in AF patients with HF accompanied by preserved, mid-range, or reduced ejection fraction (HFpEF, HFmrEF, or HFrEF, respectively).<h4>Methods</h4>Echocardiographic data from June 2016 to April 2020 in a prospective, multicenter, observational registry from 11,104 patients were analyzed. The follow-up duration was 2.2 years. The main outcome was composite of death and hospitalization. We categorized patients according to the HF type and resting HR: ≤ 60 bpm, 61-80 bpm, 81-110 bpm, and >110 bpm.<h4>Results</h4>A total of 1,421 patients were enrolled in the study: 582 in t","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-05T00:27:37.669Z","creation":"2025-04-05T00:27:37.669Z"},"accession":"S-EPMC8980522","cross_references":{"pubmed":["35391851"],"doi":["10.3389/fcvm.2022.787869"]}}